Search results
Results from the WOW.Com Content Network
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. The company's dividend is $0.42 per share quarterly, or $1.68 annually. It's ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Pfizer also offers one of the highest dividend yields among a peer group of global drugmakers -- currently at 5.8%, based on its $0.42-per-share quarterly payout.
Shares of Pfizer offer an eye-popping 6.1% dividend yield at recent prices. Is the stock a buy for income-seeking investors? Is the stock a buy for income-seeking investors?
Pfizer stock's starting dividend yield is currently 5.5%, higher than Abbott Labs and Johnson & Johnson. The dividend equates to roughly 65% of Pfizer's estimated 2024 earnings, so management ...
Pfizer has long been a dividend-paying stock and built a solid reputation by raising it for 14 consecutive years. Today, the dividend yield stands out more than the company's growth. Its current 6 ...
3. Altria Group. Despite declining tobacco use in the United States, Altria Group (NYSE: MO) has managed to maintain its revenue and grow its dividend for years. That's thanks to its strong ...
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY). Both ...